Received Aug 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
nausea; light vomiting; headache; extremely ill; This non-serious case was reported by a consumer and described the occurrence of nausea in a 79-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 02-AUG-2025, the patient received Shingles vaccine. In AUG-2025, an unknown time after receiving Shingles vaccine, the patient experienced nausea (Verbatim: nausea), vomiting (Verbatim: light vomiting), headache (Verbatim: headache) and unwell (Verbatim: extremely ill). The outcome of the nausea and vomiting were not resolved and the outcome of the headache and unwell were not reported. It was unknown if the reporter considered the nausea, vomiting, headache and unwell to be related to Shingles vaccine. It was unknown if the company considered the nausea, vomiting, headache and unwell to be related to Shingles vaccine. Additional Information: GSK receipt date: 02-AUG-2025 The patient reported that he was healthy but this vaccine made him extremely ill, nausea, light vomiting and severe headache. The expiry date of Shingles vaccine was unknown.